Improved market share in FY19 Despite the ongoing pain in the PV sales, Subros was able to increase its market share from 40% to 42% in the PV segment. The increased share was on account of new business from Maruti and M&M.; Client wise Subros market share stood at Maruti (74%), Tata motors (35%), M&M; 30%, Renualt 25% and Nissan 25%. The company expects its market share to improve further on...
Aurobindo Pharma's revenue grew 31% on a YoY basis to `5292 crs. in Q4. Growth was led by all business segments with the US and growth markets reporting sharp growth of 43% and 38% respectively on a YoY basis. Consolidated EBITDA increased to `1,060 Cr vs. `804 Cr in Q4 last year, an increase of...
Gross margin contracted by 220 bps Y-O-Y led by input cost pressure. EBIDTA decreased by 6% Y-O-Y to `82.6 crs in the quarter. On EBIDTA margins front, there was 210 bps contraction largely led by employees and advertisement expenses....
Net Revenues grew 24% YoY to `1359crs. led by robust volume growth of 12.3%. EBITDA grew by 27% YoY to `218crs while EBITDA margins expanded by 30bps to16.1%. PAT for Q1CY19 increased by 103% YoY to `40crs. VBL now accounts for ~80%+ of PepsiCo India's beverage sales in India from 51% earlier. The company has also expanded its presence...
Sales volume declined as company has lost a 10-year-old client that contributed 5% to sales in FY19 (2000 MT @ `50 crs). The client has decided to backward integrate and start its own manufacturing unit. The company have added 20 new clients with total quantum of 500 tonnes p.a....
Cipla reported a strong set of numbers with revenue/EBITDA/PAT growth of 19%/75%/54% (adjusted for an exceptional item in Q4FY18). Revenue growth during the quarter was driven by India (11%), North America (53%), and Europe (73%) business. For FY19, revenue grew by 9% aided by India (7%) and North America (29%) markets while African tendering arm remained under pressure. EBITDA grew by 75% YoY to `972 Cr during the quarter. EBITDA margins for the quarter stood at 22%, expansion of ~700bps YoY. Net profit was reported at `358 Cr for the quarter....
3W volumes were almost flat for Q4FY19 (growth 6% QoQ). Growth in this segment was mainly because of exports (growth 34% YoY). The Company sold the highest ever number of units in the current fiscal. Exports to Egypt may remain under pressure because of regulatory concerns. This may create a hang on the 3W business as Egypt is...
Godrej Consumer Products Ltd (GCPL) declared its Q4FY19 results recently. Consolidated net sales declined by 2.7% Y-O-Y in Q4FY19 to `2430crs. India business sales growth was flat for the quarter to `1325crs. due to poor performance in Household Insecticides. Volume for the...
Gross margin reduced by 60 bps to 50.9% Y-O-Y on account of inflated crude oil prices. However, Operating profit increased by 13% Y-O-Y to `2321crs in Q4FY19. The EBITDA margin stood at 23.3% as opposed to 22.5% in Q4FY18, an expansion of 80bps. led by a reduction in employee cost, advertisement expenses, and other expenses by 40 bps, 70...
Sun Pharma Advanced Research Company (SPARC) is a clinical-stage biopharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery....
Medium and small enterprises are businesses that are yet to achieve the size and scale of their market leaders and thereby offer investors with supernatural growth potential owing to their low base. Out of the 4500+ stocks listed on the domestic stock bourses, ~98% belong to the mid and small cap category and contribute ~28% of the overall market capitalisation of the total listed universe. In a developing country like India, these business enterprises play an extremely critical role in employment generation, economic upliftment of society, provide an influx of innovative products & services into the market and improve overall efficiency and productivity of the economy. As per the latest SEBI guidelines, stocks are classified based on market capitalisation where top 100 are large cap stocks, 101st to 250th are mid cap stocks and 250th and beyond are small cap stocks. Mid and small cap stocks given their relatively lower cash flow generation abilities and limited access to cheaper capital access...
Varun Beverages Ltd. declared its Q4CY18 results recently. Net Revenues grew by 49% YoY to `786crs. led by robust volume growth of 40%. EBITDA for Q4CY18 grew by 46% on a YoY basis to `48crs. Margins merely contracted by 10bps to 6.1%. Net loss for Q4CY18 decreased by 1.7% YoY to `71.5 crs. VBL now account for 80%+ of PepsiCo India's...
In Vietnam, Sales has declined by ~24% Y-O-Y in Q3FY19. We believe debt free status, better product mix and additional spray-dried capacity of 3500 ton by Q4FY20 would bring strong revenue and profitability growth in Vietnam. The management has guided 80% capacity utilisation for FY19 vs 60-70% in FY18. Incentives offered by Vietnamese government of zero tax rates will continue further....
Aurobindo Pharma's revenue grew 22% on a YoY basis to `5270 crs. in Q3. Growth was led by all business segments and markets. US and growth markets reported growth of 27% and 36% respectively on a YoY basis. Consolidated EBITDA increased to `1,086 Cr vs. `1,025 Cr in Q3 last year, an increase of...
Britannia Industries Ltd. reported Q3FY19 results with net revenue of `2827crs with growth of 10.5%. EBITDA expanded by 40 bps Y-O-Y to 15.9% in Q3FY19. Volumes grew by 7% while price and product mix contributed 2% each to the growth. The company continued to focus on...
Overall realizations grew by 0.7% YoY (Automotive division realization grew 0.4% YoY and Tractor division realization grew 2.4% YoY.) Net Sales grew by 12.2% YoY to `128.9bn. EBITDA margins contracted on a YoY basis by 152bps to 13.2%....
Subros reported Q3FY19 results. Following are the key highlights: o Net Sales rose by 13.8% (YoY) to `5.1bn o EBITDA Margins expanded by 51bps on a YoY basis to 11.1%...
Nocil reported steady Q3FY19 numbers in challenging business environment Domestic automobile growth has witnessed muted growth during 9MFY19 largely on account of extreme swings in crude oil prices, higher upfront costs to customers due to change in regulatory measures relating to insurance and the recent NBFC liquidity woes. On the global front, automobile demand scenario was even more grave as the largest auto market China registered ~3% YoY de-growth in 2018 mainly triggered by the increasing trade war tensions with the US. Despite all these challenges Nocil has recorded a steady quarter with net sales coming in at `261.2 crore (up 4.2% YoY, down 4.0%...
